Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Listening...

Search Results

No Results

    Sorry, I don't understand. Please try again

    1. Home/
    2. News/
    3. Innovation/
    4. 4 ways Johnson & Johnson has helped cultivate future STEM leaders
    A photo of people working with drones

    4 ways Johnson & Johnson has helped cultivate future STEM leaders

    In 2018, an estimated 20% of all U.S. jobs will require a high level of knowledge in science, technology, engineering or math—commonly referred to as STEM fields.

    You’ve probably heard a lot about these hot careers in the news as of late, but helping to prep and nurture the STEM movers and shakers of tomorrow certainly isn’t a new concept for Johnson & Johnson.

    Over the past 25 years, the company has created several programs specifically designed to help everyone from grade schoolers to women succeed in future STEM careers.

    Initiatives like the new WiSTEM2D Scholars Program, which starts taking applications September 1.

    The program—which is open to nontenured assistant female professors or the global equivalent at tenure-granting accredited academic universities, institutions or design schools—will fund one woman per area of STEM2D concentration: science, technology, engineering, math, manufacturing and design.

    The six award winners will receive $150,000 in funding over three years, as well as support from Johnson & Johnson mentors and other industry leaders.

    Learn more about how Johnson & Johnson hopes to ignite future STEM2D breakthroughs through this program and others in this infographic.


    4 Ways Johnson & Johnson Has Helped Cultivate Future STEM Leaders

    Wanted: The women leaders of tomorrow

    Learn how Johnson & Johnson is igniting the power of women to inspire the next generation of healthcare movers and shakers.

    More from Johnson & Johnson

    Johnson & Johnson named to The Wall Street Journal’s 2026 Best Companies for the Future list

    The company’s ability to evolve as it tackles the world’s toughest health challenges has helped Johnson & Johnson earn its spot as the top-ranked healthcare company on the list.

    Striving for a cure for multiple myeloma: What HCPs need to know

    Jordan Schecter, M.D., leader of Johnson & Johnson’s end-to-end development strategy for multiple myeloma, shares insight on the evolving treatment landscape of this rare blood cancer.

    The future of immunology

    Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.